Jun 30, 2022 | BioForward Member News
French drugmaker Sanofi on Monday said the COVID-19 vaccine candidate it has developed jointly with GSK in two trials showed a potential to protect against the virus’s main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster jab....
Jun 29, 2022 | BioForward Member News
At the Steenbock Symposium on June 7 and 8, 2022, the University of Wisconsin–Madison Department of Biochemistry opened its doors in celebration of two new research centers that bring to campus advanced biomolecular imaging technology called cryo-electron microscopy....
Jun 28, 2022 | BioForward Member News
The finding has implications for future treatment of retinal diseases that cause blindness, including age-related macular degeneration and rare diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and Best disease. People living with these...
Jun 27, 2022 | BioForward Member News
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The Food and Drug Administration’s action follows its advisory panel’s unanimous recommendation for...
Jun 24, 2022 | BioForward Member News
U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. The Food and Drug Administration’s action follows its advisory panel’s unanimous recommendation for...